France· FR:60498751
DEPRENYL 5 mg, comprimé sécable
A selegiline product containing chlorhydrate de sélégiline, registered in France by ORION CORPORATION, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Selegiline is registered in 14 of 19 countries.
Countries holding a registration under ATC N04BD01 (selegiline), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Selegiline · ATC N04BD01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of selegiline costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.24 in Italy to $0.62 in France — a ×2.5 gap.
- France: $0.62 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Selegiline · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- FR France$0.62
- IT Italy$0.24
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE SÉLÉGILINE
- Manufacturer
- ORION CORPORATION
- Country
- France (FR)
- ATC code
- N04BD01
- ATC class
- Selegiline
- Defined daily dose
- 5 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip1334009398358151 flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)
- cip1334009398359831 flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)EUR 16.23
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
187 interactions on record for selegiline.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Selegiline · interactions on record
187 records
- 35 severe
- 115 moderate
- 1 minor
- 21 info
Most severe, free to view
- IsomethepteneA03AX10severe
- OpiumA07DA02severe
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
15 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Selegiline in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEldepryl 5mg tabletsOrion Pharma (UK) Ltd
- United StatesSelegiline HydrochlorideChartwell RX, LLC
- FinlandEldeprylOrion Corporation
- ItalyJUMEXCHIESI ITALIA S.P.A.
- NorwayEldeprylOrion Corporation
- SwedenEldepryl 5 mg TablettOrion Corporation
- IrelandEldepryl 5 mg TabletsOrion Corporation
- CzechiaSELEGOS
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Eldepryl
- Bulgaria · Jamax, Селегос
- Cyprus · Selegos, Selex
- Germany · Selegilin Neuraxpharm
- Denmark · Eldepryl
- Spain · Plurimen
- Finland · Eldepryl
- United Kingdom (Northern Ireland) · Eldepryl, Selegiline Hydrochloride Activase Pharmaceuticals
- Greece · Feliselin
- Ireland · Eldepryl
- Italy · Jumex, Selecom
- Luxembourg · Eldepryl
- Latvia · Eldepryl
- Norway · Eldepryl
- Poland · Selgres
- Portugal · Selegilina Generis
- Romania · Selegos
- Sweden · Eldepryl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/91b8bf44-0670-4336-84c2-6eb3222ff743 GET /v1/drugs/91b8bf44-0670-4336-84c2-6eb3222ff743?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60498751",
"date_amm": "1987-12-04",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE SÉLÉGILINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about selegiline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.